Is Archit Organosys overvalued or undervalued?

As of 22 August 2025, the valuation grade for Archit Organosys has moved from very attractive to attractive, indicating a shift in perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 96.20, an EV to EBITDA of 18.83, and a ROCE of just 1.27%.
In comparison with peers, Archit Organosys has a significantly higher PE ratio than Godrej Industries, which stands at 43.06, and a similar EV to EBITDA ratio compared to its peers. Notably, Solar Industries is categorized as very expensive with a PE of 106.29, while Gujarat Fluoroch also falls into the very expensive category with a PE of 60.25. Despite a strong historical performance over the long term, recent stock returns have lagged behind the Sensex, with a 1-year return of -8.08% compared to the Sensex's 0.31%.